08.01.2016

A team of researchers at Kansas State University, in collaboration with Garcia-Sastre of the Icahn School of Medicine at Mount Sinai, has developed a vaccine that protects poultry from multiple strains of avian influenza found in the U.S., including H5N1, H5N2 and H5N8. The vaccine has the potential to be administered through water or into embryonated eggs, making it easier for poultry producers to vaccinate flocks.
The vaccine, called NDV-H5Nx, protects chickens and likely other poultry against the three recently introduced U.S. avian influenza strains H5N1, H5N2 and H5N8, as well as against Newcastle disease virus.
The NDV-H5Nx vaccine also has the potential to be administered to millions of birds at a time through water.
The vaccine also has potential to be administered to developing chicks in eggs.
Additionally, the NDV-H5Nx vaccine has the ability to differentiate infected from vaccinated animals, or DIVA. 
Researchers developed the NDV-H5Nx vaccine with a recombinant virus technique.